The U.S. and China restarted their trade talks, but signs are showing a comprehensive deal could be a long way off, if it happens at all.Marketsread more
The Swiss Federal Data Protection and Information Commissioner said on Tuesday it had not yet been contacted by Facebook about overseeing privacy protections for the Libra...Technologyread more
Stone, 66, a notorious Republican political operative who has described himself as a "dirty trickster," had previously been dressed down by the judge for his public remarks...Politicsread more
The Biden team's second quarter Federal Election Commission filing shows that the campaign wrote a check of just over $5,300 on June 28 to Sheehan Associates for "strategic...2020 Electionsread more
Spotify stock plunged over 1% on a report that Apple is spending money to create its own original podcasts.Technologyread more
The speech comes as market participants are strongly anticipating a rate cut at the July 30-31 Federal Open Market Committee policy meeting.The Fedread more
American consumers are flexing their muscles, and that's helping to save the economy from even slower growth as it faces what could be a protracted trade war.Market Insiderread more
The Dow slipped from a record high set earlier in the day after President Trump cast doubt on the trade progress between China and the U.S.US Marketsread more
Oil prices turned lower on Tuesday, falling by about $2 a barrel as U.S. President Donald Trump said progress has been made with Iran, signaling tensions could ease in the...Energy Commoditiesread more
McDonald's said Tuesday that it is adding DoorDash as a new delivery partner, bringing an end to its exclusive partnership with UberEats.Restaurantsread more
There's a new opportunity emerging due to the divergence between "value" stocks and "defensive" stocks, a top J.P. Morgan strategists saysInvestingread more
Responding to a growing call on Wall Street for conglomerates to split up, Johnson & Johnson CFO Dominic Caruso said Tuesday that J&J's three units of pharma, medical devices and consumer products are stronger as one company.
"We have a long track record of performing very well in all three of those markets," Caruso told CNBC's "Squawk Box. " He said the stock most of the time trades above "what's commonly known as 'sum of the parts' analysis."
Shares of J&J were slightly higher in premarket trading on Tuesday, after the company's earnings report beat estimates and revenue matched expectations. The health-care giant also raised its yearly outlook.
The company said worldwide pharmaceutical sales of $8.2 billion for the first quarter represented a 5.9 percent increase from the year-ago period. Medical-device sales saw a 2.4 percent decline to $6.1 billion. Consumer sales fell 5.8 percent to $3.2 billion.
Overall, New Jersey-based J&J reported adjusted first-quarter profit of $1.68 per share, a 7.7 percent increase from the year-ago period. Revenue of nearly $17.5 billion rose 0.6 percent from the first quarter 2015.
Johnson & Johnson expects full-year earnings in the range of $6.53 to $6.68 per share, with revenue in the range of $71.2 billion to $71.9 billion, reflecting current foreign currency exchange rates.
As for possible M&A opportunities with biotech valuations coming down, Caruso said J&J is "obviously looking very closely at the field."
"[But] I'm not sure the owners of those companies agree the current valuations are at the right place. So we'll continue to work through various acquisition proposals," he added. "We want to do the right deal, at the right time, with the right partner, at the right valuation."
Johnson & Johnson shares, as of Monday's close, have increased 8 percent since the beginning of the year, while the index has climbed 2.5 percent. The stock has risen 11 percent in the last 12 months.
— Associated Press contributed to this report.